FDA Application
-
NDC Search Results on Active Ingredient: fluticasone propionate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0378-9320-32 | Mylan Pharmaceuticals Inc. | ANDA208891 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68071-4868-5 | NuCare Pharmaceuticals,Inc. | ANDA076504 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68071-4156-5 | NuCare Pharmaceuticals,Inc. | ANDA077570 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68071-1638-5 | NuCare Pharmaceuticals,Inc. | ANDA078492 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68071-2582-5 | NuCare Pharmaceuticals,Inc. | ANDA077538 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 71143-375-01 | OptiNose US, Inc. | NDA209022 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 71143-375-98 | OptiNose US, Inc. | NDA209022 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 71143-375-99 | OptiNose US, Inc. | NDA209022 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; AZELASTINE HYDROCHLORIDE | 45802-066-01 | Padagis Israel Pharmaceuticals Ltd | ANDA208111 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 45802-222-37 | Padagis Israel Pharmaceuticals Ltd | ANDA076793 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 45802-221-35 | Padagis Israel Pharmaceuticals Ltd | ANDA076668 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 45802-222-11 | Padagis Israel Pharmaceuticals Ltd | ANDA076793 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 45802-222-35 | Padagis Israel Pharmaceuticals Ltd | ANDA076793 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 45802-221-11 | Padagis Israel Pharmaceuticals Ltd | ANDA076668 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 45802-221-37 | Padagis Israel Pharmaceuticals Ltd | ANDA076668 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 45802-441-02 | Padagis Israel Pharmaceuticals Ltd | ANDA091553 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 66993-080-96 | Prasco Laboratories | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 66993-585-97 | Prasco Laboratories | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 66993-790-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 66993-079-96 | Prasco Laboratories | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 66993-791-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 66993-584-97 | Prasco Laboratories | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 66993-086-96 | Prasco Laboratories | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 66993-792-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 66993-087-96 | Prasco Laboratories | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 66993-586-97 | Prasco Laboratories | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 66993-088-96 | Prasco Laboratories | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 66993-078-96 | Prasco Laboratories | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 68788-8446-1 | Preferred Pharmaceuticals Inc. | ANDA076504 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68788-6926-1 | Preferred Pharmaceuticals Inc. | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
| 301-330 | 331-360 | 361-390 | 391-420 | 421-426 |
-
